Covid-19News
July 1, 2020

COVID-19 updates

Covid-19News
July 1, 2020

Howe does COVID-19 affect liver patients

News
June 29, 2020

A Deeper Dive into NASH Diagnosis and Treatment: An Augmented Reality Experience

News
June 29, 2020

COVID 19 and Fatty Liver Disease

News
June 29, 2020

What the Future Holds for NASH: An Augmented Reality Look into Disease Stating and Targeted Therapies

News
June 29, 2020

Genfitwarns costs offailed NASH trialwill drag deep into2020

News
June 29, 2020

Semaglutide testing in Treating NASH

Research
June 29, 2020

NASH Has Gone Under the Radar, but It Is the _Elephant in the Room,_ Panelists Say

News
June 29, 2020

Fatty Liver Program

News
June 29, 2020

NAFLD or NASH: Have you been diagnosed?

News
June 29, 2020

NAFLD/NASH: Am I at Risk?

News
June 29, 2020

Pediatric NAFLD/NASH

News
June 29, 2020

Fatty liver, a silent epidemic: The disease can remain asymptomatic for decades

News
June 29, 2020

What is non-alcoholic steatohepatitis (NASH)?

News
June 29, 2020

NASH-linked gene discovery could inspire new drugs to treat liver damage

News
June 29, 2020

COVID-19 and Chronic Liver Disease

News
June 29, 2020

Bristol-Myers pens $100M NASH, fibrosis drug deal with Japan’s Nitto

News
June 29, 2020

ADA: NGM backs up case for once-monthly dosing of Merck-partnered NASH drug

News
June 29, 2020

A map of liver cells provides insights that could boost search for NASH drugs

News
June 29, 2020

Genfit’s elafibranor en route to NASH graveyard with phase 3 flop

Lifestyle Matters!
June 29, 2020

Why do we need a NASH drug? NASH leaders weigh in

Lifestyle Matters!
June 29, 2020

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way

Lifestyle Matters!
June 15, 2020

Gluten & Meat Substitutes

ArticlesLinks & Resources
June 12, 2020

International Liver day

Click here to visit www.international-nash-day.com
ArticlesLinks & Resources
May 24, 2020

liver systems- multiple diagrams

ArticlesLinks & Resources
May 24, 2020

Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells

ArticlesNews
May 24, 2020

Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment

ArticlesLinks & Resources
May 24, 2020

Nonalcoholic fatty liver disease – Symptoms and causes – Mayo Clinic

ArticlesResearch
May 24, 2020

Nutrition Action diabetes article

ArticlesNews
May 24, 2020

Zydus Cadila scores first ever NASH approval, in India

Covid-19News
July 1, 2020

COVID-19 updates

Covid-19News
July 1, 2020

Howe does COVID-19 affect liver patients

Covid-19Links & Resources
May 12, 2020

Chronic Liver Disease and Coronavirus

Covid-19
May 4, 2020

COVID-19 and Chronic Liver Disease – WebMd

More than 4 in 5 people who have symptoms of COVID-19, the illness caused by the new coronavirus, get only mildly sick. But if you have ongoing health issues, including…
Research
June 29, 2020

NASH Has Gone Under the Radar, but It Is the _Elephant in the Room,_ Panelists Say

ArticlesResearch
May 24, 2020

Nutrition Action diabetes article

Research
May 17, 2020

Genfit’s elafibranor en route to NASH graveyard with phase 3 flop

Research
May 5, 2020

Common myths about cirrhosis

Lifestyle Matters!
June 29, 2020

Why do we need a NASH drug? NASH leaders weigh in

Lifestyle Matters!
June 29, 2020

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way

Lifestyle Matters!
June 15, 2020

Gluten & Meat Substitutes

Lifestyle Matters!Links & Resources
May 12, 2020

The Role of the Toxic Food Environment in the Obesity Epidemic

Want to formulate an awareness program in your community?